Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)

SHA:600165 Revenue

Ningxia Zhongke Biotechnology had revenue of 117.65M CNY in the quarter ending March 31, 2026, with 25.40% growth. This brings the company's revenue in the last twelve months to 468.31M, up 21.56% year-over-year. In the year 2025, Ningxia Zhongke Biotechnology had annual revenue of 444.48M with 28.72% growth.

• Revenue (ttm): 468.31M
• Revenue Growth: +21.56%
• P/S Ratio: 10.52
• Revenue / Employee: 561.52K
• Employees: 834
• Market Cap: 4.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	444.48M	99.16M	28.72%
Dec 31, 2024	345.32M	59.63M	20.87%
Dec 31, 2023	285.69M	-395.44M	-58.06%
Dec 31, 2022	681.13M	432.42M	173.86%
Dec 31, 2021	248.72M	129.60M	108.80%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error